Risk of Cardiovascular Conditions in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Gosmanova, Elvira O.
Funding for this research was provided by:
This research was funded by Shire Human Genetic Therapies, Inc., a Takeda company, Lexington, MA, USA.
Text and Data Mining valid from 2021-06-24
Version of Record valid from 2021-06-24
19 March 2021
10 May 2021
24 June 2021